OOIR: Observatory of International Research

Papers

(The H4-Index of Rheumatology is 45. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-10-01 to 2024-10-01.)

Article	Citations
Lupus nephritis: clinical presentations and outcomes in the 21st century	115
Osteosarcopenia: where osteoporosis and sarcopenia collide	111
Herpes zoster following BNT162b2 mRNA COVID-19 vaccination in patients with autoimmune inflammatory rheumatic diseases: a case series	100
Incidence and severeness of COVID-19 hospitalization in patients with inflammatory rheumatic disease: a nationwide cohort study from Denmark	98
Baricitinib improves respiratory function in patients treated with corticosteroids for SARS-CoV-2 pneumonia: an observational cohort study	98
Long-term outcomes in systemic lupus erythematosus: trends over time and major contributors	95
COVID-19 vaccination and antirheumatic therapy	94
Incidence and prevalence of systemic sclerosis globally: a comprehensive systematic review and meta-analysis	88
Treating systemic lupus erythematosus in the 21st century: new drugs and new perspectives on old drugs	86
Diagnostic delay in axial spondyloarthritis: a systematic review and meta-analysis	85
Difficult-to-treat rheumatoid arthritis: contributing factors and burden of disease	84
A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies	82
Abatacept in interstitial lung disease associated with rheumatoid arthritis: national multicenter study of 263 patients	77
Prevalence and impact of comorbidities in axial spondyloarthritis: systematic review and meta-analysis	74
The safety of JAK-1 inhibitors	73
VEXAS syndrome in a woman	72
Genetics and epigenetics in primary Sjögren’s syndrome	72
British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids	70
The management of neuropsychiatric lupus in the 21st century: still so many unmet needs?	68
Rituximab in the treatment of systemic sclerosis–related interstitial lung disease: a systematic review and meta-analysis	68
Prognostic values of anti-Ro52 antibodies in anti-MDA5-positive clinically amyopathic dermatomyositis associated with interstitial lung disease	67
Classification vs diagnostic criteria: the challenge of diagnosing axial spondyloarthritis	67
Sex and gender differences in axial spondyloarthritis: myths and truths	66
Correlation between pain severity and levels of anxiety and depression in osteoarthritis patients: a systematic review and meta-analysis	63
Is fibromyalgia associated with a unique cytokine profile? A systematic review and meta-analysis	61

Classifying and diagnosing systemic lupus erythematosus in the 21st century	59
Treatment of Sjögren’s syndrome: current therapy and future directions	58
Phase 2, randomized, placebo-controlled trial of dapirolizumab pegol in patients with moderate-to-severe active systemic lupus erythematosus	58
Glycine increased ferroptosis via SAM-mediated GPX4 promoter methylation in rheumatoid arthritis	56
Rheumatoid arthritis related interstitial lung disease – improving outcomes over 25 years: a large multicentre UK study	53
JAK inhibitors are effective in a subset of patients with juvenile dermatomyositis: a monocentric retrospective study	53
Association between environmental air pollution and rheumatoid arthritis flares	52
The role of chest CT in deciphering interstitial lung involvement: systemic sclerosis versus COVID-19	52
Prevalence, incidence and cause-specific mortality of rheumatoid arthritis–associated interstitial lung disease among older rheumatoid arthritis patients	52
British Society for Rheumatology guideline on management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathy	50
Clinical course of 602 patients with Takayasu's arteritis: comparison between Childhood-onset versus adult onset disease	49
An association between chronic widespread pain and the gut microbiome	49
Atypical splice-site mutations causing VEXAS syndrome	48
Data-driven definitions for active and structural MRI lesions in the sacroiliac joint in spondyloarthritis and their predictive utility	47
The risk of infections in adult patients with systemic lupus erythematosus: systematic review and meta-analysis	47
Characteristics of patients with difficult-to-treat rheumatoid arthritis in clinical practice	47
Temporal relationship between osteoarthritis and comorbidities: a combined case control and cohort study in the UK primary care setting	47
Risk of venous thromboembolism associated with tofacitinib in patients with rheumatoid arthritis: a population-based cohort study	47
Resolution of vascular inflammation in patients with new-onset giant cell arteritis: data from the RIGA study	46
Socioeconomic status and occurrence of chronic pain: a meta-analysis	45
Telemedicine in rheumatology: a mixed methods study exploring acceptability, preferences and experiences among patients and clinicians	45